Hematology

Latest News

FDA Accepts Exa-cel BLA for Sickle Cell and Transfusion-Dependent β-Thalassemia
FDA Accepts Exa-cel BLA for Sickle Cell and Transfusion-Dependent β-Thalassemia

June 9th 2023

CRISPR Therapeutics and Vertex Pharmaceuticals completed their rolling submissions in April 2023.

CGTLive’s Weekly Rewind – June 9, 2023
CGTLive’s Weekly Rewind – June 9, 2023

June 9th 2023

Legend Biotech Seeks Expanded Use for Cilta-cel in Lenalidoimide-Refractory Multiple Myeloma
Legend Biotech Seeks Expanded Use for Cilta-cel in Lenalidoimide-Refractory Multiple Myeloma

June 9th 2023

Around the Helix: Cell and Gene Therapy Company Updates – June 7, 2023
Around the Helix: Cell and Gene Therapy Company Updates – June 7, 2023

June 7th 2023

Study Assessing Vibecotamab in MRD+ AML and MDS/CMML After Hypomethylating Agents
Study Assessing Vibecotamab in MRD+ AML and MDS/CMML After Hypomethylating Agents

June 7th 2023

Video Interviews

More News

© 2023 MJH Life Sciences

All rights reserved.